Growblox Sciences, a biopharmaceutical
research and development company focused on the production of consistent
medicinal cannabis, announced on Monday the launch of its new corporate
website.
“We have navigated many obstacles in the
process of refining our vision and gathering a complete understanding of the
medicinal cannabis landscape,” stated Craig Ellins, the company’s Chief
Executive Officer. “Growblox is here to cultivate an industry, not just a
plant.”
The medicinal cannabis industry is
continuing to expand, particularly in the United States. In addition to four
states and Washington D.C. moving to legalize recreational use of cannabis in
recent months, 19 states currently have laws on the books that allow for
medicinal use of the plant. As public support for marijuana continues to rise,
climbing to 55 percent in 2014, according to a survey by CNN, additional
channels for scientific inquiry should allow the industry to flourish,
particularly from a medicinal perspective.
With a focus on science and research,
Growblox is in a strong position to grow with the industry. The company’s new
website provides potential investors with an extensive supply of content
regarding Growblox’s operating divisions: GB Sciences, GB Solutions and GB
Products.
GB Sciences, led by the company’s Chief
Science Officer, Dr. Andrea Small-Howard, is responsible for regulatory,
compliance, clinical trials, product claim validation and new drug discovery.
GB Solutions focuses on logistical details of the company under the leadership
of Puerto Rican business leader Cesar Cordero-Kruger. GB Products, which is
currently scheduled for launch by the end of Q3 2015, will handle product
design and marketing efforts under the leadership of Growblox Co-founder Lucas
Marin.
Through the launch of its new corporate
site, Growblox is initializing a new communication strategy designed to target
potential partners and investors. This plan should allow the company to
continue to increase market share in the fast growing medical cannabis space.
By merging state-of-the-art technologies in plant biology, cultivation and post-production
processes, the company is pioneering industry-leading processes to produce
safe, consistent medical cannabis. With the increasing demands of the industry,
Growblox should be in a strong position to make significant strides moving
forward.
For more information, visit
www.gbsciences.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment